This axis drives HG-induced podocyte injury by amplifying OS, apoptosis, and inflammatory cascades, thereby positioning the TCF7/miR-16-5p/SEMA3A axis as a potential therapeutic target in DN. This evidence concerns the gene TCF7 and liver dysplastic nodule.